
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR/Cas-based CAR-T cells: production and application
Ping Song, Qiqi Zhang, Zhiyong Xu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Ping Song, Qiqi Zhang, Zhiyong Xu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
From Gene Editing to Tumor Eradication: The CRISPR Revolution in Cancer Therapy
Ashiq Ali, Urooj Azmat, Aisha Khatoon, et al.
Progress in Biophysics and Molecular Biology (2025)
Closed Access
Ashiq Ali, Urooj Azmat, Aisha Khatoon, et al.
Progress in Biophysics and Molecular Biology (2025)
Closed Access
Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: a clinical perspective
Alessandro Lavoro, Daria Ricci, Giuseppe Gattuso, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Alessandro Lavoro, Daria Ricci, Giuseppe Gattuso, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
mRNA lipid nanoparticles in CAR-T therapy: a novel strategy to improve efficacy
Zengkai Zhao, Mingmei Li, Zheng Xiang, et al.
Nanotechnology (2025) Vol. 36, Iss. 22, pp. 222003-222003
Closed Access
Zengkai Zhao, Mingmei Li, Zheng Xiang, et al.
Nanotechnology (2025) Vol. 36, Iss. 22, pp. 222003-222003
Closed Access
In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy
Weiyue Zhang, Xin Huang
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Weiyue Zhang, Xin Huang
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy
Ahmad Bairqdar, Polina E. Karitskaya, Г. А. Степанов
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13321-13321
Open Access | Times Cited: 2
Ahmad Bairqdar, Polina E. Karitskaya, Г. А. Степанов
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13321-13321
Open Access | Times Cited: 2
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Sarkar Sardar Azeez, Rahin Shareef Hamad, Bahra Kakamin Hamad, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 2
Sarkar Sardar Azeez, Rahin Shareef Hamad, Bahra Kakamin Hamad, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 2
Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies
Zewei Cheng, Xiaohan Cui, Song Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117229-117229
Open Access | Times Cited: 1
Zewei Cheng, Xiaohan Cui, Song Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117229-117229
Open Access | Times Cited: 1
BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1
Songnan Sui, Mengjun Zhong, Shuxin Zhong, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Songnan Sui, Mengjun Zhong, Shuxin Zhong, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Collagen-disruptive cell therapy: adoptive transfer of membrane-anchored, tumor cell surface vimentin-targeted interleukin 12–armed TILs suppress collagen expression to boost deep T-cell infiltration via dual signaling activation and significant CCKAR reduction.
Shulin Li
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Shulin Li
Research Square (Research Square) (2024)
Open Access | Times Cited: 1